Will Modern Genetics Turn Us Into Gene “Genies”?
By Marcy Darnovsky, Dan Sarewitz, Samuel Weiss Evans, Arvis Sulovari, Eric A. Widra,
Zócalo Public Square
| 05. 24. 2016
[Collection of brief essays]
With the ubiquitous ways we apply our knowledge of genetics today—in crop seeds, medicine, space—it’s hard to believe the story of the modern gene did not emerge until the mid-1800s. The vast implications of this discovery about how living things hand down traits to offspring have spanned the range of enlightening to horrifying, from Darwin’s theory of evolution to Nazi eugenics. Technology has enabled us with relative swiftness to move beyond test tubes to actual human cells in manipulating organisms and their genetic materials. Recent discoveries such as the new CRISPR genome editing tool have made genes easier to modify than ever.
As we gain greater power over these units of heredity, we have to ask deep questions about how far we are willing to go. Earlier this month The New York Times reported that scientists are privately discussing manufacturing the entire DNA contained in human chromosomes out of chemicals. The activity raises the specter of being able to create a human being without parents through cloning, but according to the Times report, an organizer of the proposed project...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...